A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1
- Conditions
- Substance-Related Disorders
- Registration Number
- NCT00033124
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Brief Summary
The purpose of this study is to examine behavioral treatment for methamphetamine dependence.
- Detailed Description
To characterize meth. withdrawal symptoms using a multidimensional withdrawal questionnaire; to field test and investigate the effect of using an algorithm developed for discriminating between new use and residual carry-over of meth metabolites in urine and to evaluate the treatment response of meth. users to participation in the thrice weekly psychosocial protocol to be used as a "platform" in future pharmacotherapy trials.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
Male or Female at least 18 yrs of age; DSM-4 diagnosis of methamphetamine (METH) dependence; be willing to comply with study procedures; verbalize understanding of consent and provide written consent and willingness to complete study procedures; be seeking treatment for METH dependence.
Additional criteria available during screening at the site.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Withdrawal symptoms New Use algorithm
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (5)
South Bay Treatment Center
🇺🇸Chula Vista, California, United States
Matrix Institute on Addictions
🇺🇸Costa Mesa, California, United States
John A. Burns School of Medicine
🇺🇸Honolulu, Hawaii, United States
Powell Chemical Dependency Center
🇺🇸Des Moines, Iowa, United States
Comprehensive Mental Health Services, Inc
🇺🇸Independence, Missouri, United States
South Bay Treatment Center🇺🇸Chula Vista, California, United States